| scholarly article | Q13442814 |
| P50 | author | Roger Pertwee | Q29643420 |
| Jenny L. Wiley | Q42407062 | ||
| Chris Breivogel | Q73098633 | ||
| Daniele Bolognini | Q93139102 | ||
| P2093 | author name string | Billy R Martin | |
| Robert E Vann | |||
| John W Huffman | |||
| Anu Mahadevan | |||
| Raj K Razdan | |||
| D Matthew Walentiny | |||
| Maria Grazia Cascio | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| An investigation into the structural determinants of cannabinoid receptor ligand efficacy | Q33861944 | ||
| The cannabinoid 1-receptor silent antagonist O-2050 attenuates preference for high-fat diet and activated astrocytes in mice | Q34099625 | ||
| SR141716A, a potent and selective antagonist of the brain cannabinoid receptor | Q34332716 | ||
| Inverse agonism and neutral antagonism at cannabinoid CB1 receptors | Q34388049 | ||
| Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations. | Q34410764 | ||
| Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol | Q34476479 | ||
| Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'. | Q34479817 | ||
| Endocannabinoids in cognition and dependence | Q34673164 | ||
| Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice | Q34846838 | ||
| Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine | Q35041929 | ||
| CB1 cannabinoid receptor-mediated modulation of food intake in mice | Q35048878 | ||
| Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication | Q35226616 | ||
| The endocannabinoid system in brain reward processes | Q36741861 | ||
| Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice | Q37339113 | ||
| SR141716A is an inverse agonist at the human cannabinoid CB1 receptor | Q42445979 | ||
| Delta(9)-tetrahydrocannabinol enhances an increase of plasma corticosterone levels induced by forced swim-stress. | Q43232672 | ||
| Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain | Q44014642 | ||
| Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity | Q44122181 | ||
| SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study | Q44176704 | ||
| (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens | Q44228316 | ||
| Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols | Q44356912 | ||
| 6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist | Q44806888 | ||
| Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists | Q44863367 | ||
| Antinociceptive effects of tetrahydrocannabinol side chain analogs: dependence upon route of administration | Q44872680 | ||
| Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol | Q44965916 | ||
| Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. | Q45081374 | ||
| In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity | Q45096581 | ||
| Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol | Q45103517 | ||
| Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. | Q45113533 | ||
| Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles | Q45217781 | ||
| Substituted 3-(phenylmethyl)-1H-indole-5-carboxamides and 1-(phenylmethyl)indole-6-carboxamides as potent, selective, orally active antagonists of the peptidoleukotrienes | Q46159103 | ||
| Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats | Q46819535 | ||
| A neutral CB1 receptor antagonist reduces weight gain in rat. | Q46932962 | ||
| Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. | Q47921662 | ||
| Endogenous cannabinoid system as a modulator of food intake | Q61479731 | ||
| Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes | Q71407604 | ||
| Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist | Q72302099 | ||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| cannabinoid receptor | Q421237 | ||
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 96-105 | |
| P577 | publication date | 2010-11-27 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist | |
| P478 | volume | 651 |
| Q37578979 | A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors |
| Q57299911 | Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice |
| Q41668062 | Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex. |
| Q37899264 | CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant). |
| Q38848638 | Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor |
| Q34053352 | Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice |
| Q38856900 | Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs |
| Q39508113 | Identification of a Potent and Selective Cannabinoid CB1 Receptor Antagonist from Auxarthron reticulatum. |
| Q48176768 | Metabolic Profiling of CB1 Neutral Antagonists |
| Q36783972 | Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice |
| Q46814567 | O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus |
| Q91717872 | Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development |
| Q38274796 | Prostamide F(2) α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition |
| Q38025166 | Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders |
| Q36650335 | Structural analogs of pyrazole and sulfonamide cannabinoids: effects on acute food intake in mice |
| Q35818708 | Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents |
| Q64122226 | The motivation for exercise over palatable food is dictated by cannabinoid type-1 receptors |
Search more.